Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CannTrust Holdings Inc CNTTQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Cannabis
CannTrust Holdings Inc is engaged in the business of producing and distributing medical cannabis in Canada. Its facility is located at Vaughan, Ontario in Canada. Its brands include LIIV, ESCAPE, SYNR.G and Peak Leaf.


GREY:CNTTQ - Post by User

CannTrust Holdings Inc
Bullboard Posts
User Avatar Image
(3)
•••
Comment by EdiblesRlifeon Mar 07, 2019 9:49am
50 Views
Post# 29454588

RE:RE:RE:RE:Earnings Report will be great like last quarter

RE:RE:RE:RE:Earnings Report will be great like last quarterHEXO has the partnership with Molson, so they will be fine for quite a while longer. TRST is in a great financial position, with continually increasing medical patient base, operations going well in Denmark. Just need Apotex partnership to start proving fruitful. But TRST has a strong balance sheet and is not going away. Either going to be bought out or become a strong pharma-cannabis play in its own right, which it keeps building towards.


AutopiIot wrote: I think Organigram will be the next one picked up by a bigger player. The fight for survival is getting more serious every month as clock is ticking and TRST and HEXO are not proving they can make it happen. Weed stock novelty is going to wear off very soon.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities